Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Japan Pharma Sees US Revenues Grow But Policy Impact Still Unclear
Major Firms Report Fiscal Year Results
May 21 2025
•
By
Lisa Takagi
US a key driver of major Japanese pharma companies' growth last fiscal year.
(Shutterstock/AI-generated)
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Japan
More from Therapy Areas